Alcohol and Drug Dependence Treatment: Pharmacogenetics

[1]  Ming D. Li,et al.  Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron. , 2013, The American journal of psychiatry.

[2]  P. Randall,et al.  Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. , 2012, Alcoholism, clinical and experimental research.

[3]  C. Benkelfat,et al.  Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone. , 2012, Pharmacogenomics.

[4]  R. González-Sarmiento,et al.  Association of µ‐opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta‐analysis , 2012, Addiction biology.

[5]  D. Oslin,et al.  The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. , 2012, Alcoholism, clinical and experimental research.

[6]  P. Miller,et al.  Medical Treatment of Alcohol Dependence: A Systematic Review , 2011, International journal of psychiatry in medicine.

[7]  Ming D. Li,et al.  Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking. , 2011, The American journal of psychiatry.

[8]  D. Couper,et al.  An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. , 2008, Archives of general psychiatry.

[9]  R. Rosenheck,et al.  Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. , 2007, Alcoholism, clinical and experimental research.

[10]  D. Oslin,et al.  A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients , 2003, Neuropsychopharmacology.